Article

Uveitis Update: Medical, surgical options considered for uveitic glaucoma

Editor's Note: Uveitic glaucoma is often not a single disease. Multiple factors, including inflammatory mediators as well as anatomic/morphologic changes, can contribute to the development of elevated IOP. Corticosteroids used to treat the inflammation can also produce elevated IOP. It is important to try to sort out these factors in patients with uveitic glaucoma to determine what category they fit in, and then select the best treatment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.